NBC Securities
AKTS icon

NBC Securities’s Aktis Oncology AKTS Stock Holding History

NBC Securities’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108K Buy
5,567
+209
+4% +$5.09K 0.01% 1054
2026
Q2 		$173K Buy
+5,358
New +$110K 0.01% 896

Other funds holding AKTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

NBC Securities's AKTS Position: Q3 2026 in Review

NBC Securities increased its Aktis Oncology (AKTS) stake by 3.9% in Q3 2026, buying an estimated $5.09K and bringing the position to 5,567 shares worth $108K. The position accounts for 0.01% of the portfolio, ranked #1054.

NBC Securities first reported a position in AKTS in Q2 2026 and has held it in 2 quarters since. The position peaked at $173K in Q2 2026. 35 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • NBC Securities held 5,567 shares of Aktis Oncology worth $108K as of Q3 2026.
  • NBC Securities bought 209 Aktis Oncology shares in Q3 2026, an estimated $5.09K.
  • Aktis Oncology made up 0.01% of NBC Securities's portfolio in Q3 2026, its #1054 holding.
  • NBC Securities first reported a position in Aktis Oncology in Q2 2026 and has held it in 2 quarters since.
  • NBC Securities's Aktis Oncology position peaked at $173K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.